Series b redeemable convertible preferred stock, 0.0001 par value 502 and zero shares authorized as of june 30, 2026 and december 31, 2025, respectively 502 and zero shares issued and outstanding as of june 30, 2026, and december 31, 2025, respectively liquidation value of 0 as of june 30, 2026
6,767
Common stock, 0.0001 par value 300,000,000 shares authorized as of june 30, 2026 and 12,500,000 shares authorized as of december 31, 2025 25,832,969 and 1,261,685 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
2
Additional paid-in capital
642,399
Accumulated deficit
-469,380
Accumulated other comprehensive (loss) income
-63
Total stockholders' equity
172,958
Total liabilities, redeemable convertible preferred stock, and stockholders' equity
189,306
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.